Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors
- 1 December 2011
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1814 (12), 1947-1954
- https://doi.org/10.1016/j.bbapap.2011.07.023
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Kynurenine is an endothelium-derived relaxing factor produced during inflammationNature Medicine, 2010
- Indoleamine 2,3-Dioxygenase Tissue Distribution and Cellular Localization in Mice: Implications for Its Biological FunctionsJournal of Histochemistry & Cytochemistry, 2009
- Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathwayThe International Journal of Biochemistry & Cell Biology, 2009
- Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer diseaseAmino Acids, 2008
- Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cellsBlood, 2008
- Evolution of Vertebrate Indoleamine 2,3-DioxygenasesJournal of Molecular Evolution, 2007
- Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapyNature Reviews Cancer, 2007
- Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancerBritish Journal of Cancer, 2006
- Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolismBiochemical and Biophysical Research Communications, 2005
- Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-DioxygenaseThe Journal of Experimental Medicine, 2002